PROCEPT BioRobotics Corp

PRCT Nasdaq SEC CIK 1588978
Follow PROCEPT BioRobotics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $98.3M +18% vs same quarter last year
Net income −$26.5M −23.8% vs same quarter last year
EPS, diluted −$0.46 −21.1% vs same quarter last year
Operating cash flow −$9M −35.4% vs same quarter last year
Revenue by quarter
$68.2M
$69.2M
$79.2M
$83.3M
$76.4M
$83.1M
$94.5M
$98.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$100M$0$100M$200M$300M$400MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$308.1M−$95.6K
FY24$224.5M−$91.4K
FY23$136.2M−$105.9K
FY22$75M−$87.2K
FY21$34.5M−$59.9K
FY20$7.7M−$53M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−800%−600%−400%−200%0%200%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2563.7%−33.7%0%
FY2461.1%−43%0%
FY2352.2%−80.2%−0.1%
FY2249.4%−107.6%−0.1%
FY2146%−157.1%−0.2%
FY20−16.3%−619.4%−687%
FY19---
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$58.3M
FY24−$103.6M
FY23−$133.2M
FY22−$83M
FY21−$57.9M
FY20−$48.6M
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • PROCEPT BioRobotics
  • Healthcare median
−800%−600%−400%−200%0%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearPROCEPT BioRoboticsHealthcare median
FY250%−30.6%
FY240%−47%
FY23−0.1%−58%
FY22−0.1%−80.4%
FY21−0.2%−71.8%
FY20−687%−62.2%
FY19-−46.2%